Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name KN046
Trade Name
Synonyms KN 046|KN-046|Erfonrilimab
Drug Descriptions

KN046 is a bispecific monoclonal antibody that targets PD-L1 (CD274) expressed on tumor cells and CTLA-4 on T lymphocytes, potentially leading to enhanced antitumor immune response (NCI Drug Dictionary).

DrugClasses CTLA4 Antibody 22 Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 93
CAS Registry Number NA
NCIT ID C157632


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cisplatin + KN046 + Paclitaxel Cisplatin KN046 Paclitaxel 0 0
Gemcitabine + KN046 + Nab-paclitaxel Gemcitabine KN046 Nab-paclitaxel 0 0
KN046 KN046 0 1
KN046 + Lenvatinib KN046 Lenvatinib 0 0

Additional content available in CKB BOOST